Epithalon vs Epitalon: Same Peptide, Different Spelling

The supposed difference between Epithalon and Epitalon has confused researchers for decades. But the answer is simpler than most sources suggest. They're identical. Both names refer to the same four-amino-acid sequence (Ala-Glu-Asp-Gly), synthesised in laboratories worldwide under both spellings. The variation isn't scientific. It's linguistic. Russian researchers who first synthesised this peptide in the 1980s used Cyrillic script, and when transliterated into English, the same word became Epithalon in some publications and Epitalon in others.

We've worked with peptide researchers across labs using both terms interchangeably, and the molecular structure submitted for synthesis is always identical. The confusion isn't about chemistry. It's about documentation standards that evolved before international naming conventions were standardised.

What's the difference between Epithalon and Epitalon?

There is no chemical difference between Epithalon and Epitalon. They are the same tetrapeptide with the amino acid sequence alanine-glutamic acid-aspartic acid-glycine (Ala-Glu-Asp-Gly). The variation in spelling stems from transliteration differences when converting the original Russian name (Эпиталон) into English. Both terms are used in peer-reviewed research, synthesis protocols, and supplier catalogues to describe the synthetic version of the naturally occurring pineal peptide epithalamine.

Most researchers encounter this discrepancy when sourcing peptides or reviewing literature. One study uses Epithalon, the next uses Epitalon, and without context, it appears they're discussing separate compounds. They aren't. The molecular weight (390.35 g/mol), structure, and mechanism of action remain constant regardless of spelling. What matters is understanding where each term originated, why both persist, and what that means for researchers navigating supplier catalogues, regulatory documentation, and published studies.

The Origin of Both Names

Both Epithalon and Epitalon trace back to work conducted at the St. Petersburg Institute of Bioregulation and Gerontology by Professor Vladimir Khavinson in the early 1980s. The peptide was synthesised as a shorter, more stable version of epithalamine, a natural peptide extracted from the pineal glands of young animals. The Russian research team used Cyrillic script. Эпиталон. Which transliterates variably into English depending on the phonetic system applied.

English-language publications initially used both Epithalon and Epitalon interchangeably, with no consensus on which was 'correct.' Early peer-reviewed papers from Russian institutions appearing in English journals used Epithalon more frequently, while Western suppliers and synthesis labs often adopted Epitalon. Neither spelling was formally standardised by IUPAC (International Union of Pure and Applied Chemistry), which typically assigns systematic names to peptides based on their amino acid sequence rather than phonetic transliterations.

By the 2000s, both terms had embedded themselves in the research lexicon. PubMed searches return published studies using both spellings. Sometimes within the same journal across different years. This isn't a data error or a variant compound. It's a documentation artefact from an era when peptide nomenclature standards were still being formalised internationally.

What the Peptide Actually Does

Epithalon (or Epitalon. The mechanism doesn't change with the spelling) functions primarily as a telomerase activator. Telomerase is the enzyme responsible for adding repetitive nucleotide sequences to the ends of chromosomes (telomeres), which shorten with each cell division. Shortened telomeres are associated with cellular senescence. The point at which cells stop dividing and enter a state of arrested growth.

Research conducted at the St. Petersburg Institute demonstrated that Epithalon administration increased telomerase activity in human somatic cells by upregulating the hTERT gene, which codes for the catalytic subunit of telomerase. A study published in the Bulletin of Experimental Biology and Medicine found that epithalamine (the naturally occurring peptide from which Epithalon was derived) extended mean lifespan in rats by 25% compared to controls, with treated animals showing delayed tumour development and improved immune function.

The peptide also influences melatonin secretion from the pineal gland. Epithalon administration has been shown to restore circadian melatonin rhythms in aged animals, where natural melatonin production declines significantly after middle age. Melatonin regulates sleep-wake cycles, antioxidant defence, and immune modulation. Making pineal function a critical factor in age-related physiological decline.

Supplier Terminology and What It Means

When sourcing research-grade peptides, you'll encounter both Epithalon and Epitalon in supplier catalogues. Sometimes from the same supplier across different product listings. This isn't an indication of quality variance or formulation difference. It reflects the fact that peptide suppliers source from synthesis facilities worldwide, and those facilities use whichever transliteration was standard in their region or historical documentation.

Real Peptides uses standardised amino acid sequencing for all peptide synthesis, meaning the final product is verified by mass spectrometry and HPLC regardless of the name on the label. The critical specification isn't the spelling. It's the molecular confirmation: Ala-Glu-Asp-Gly with >98% purity and correct molecular weight (390.35 g/mol). Any reputable supplier will provide third-party testing certificates confirming the peptide's structure matches the intended sequence.

Researchers should verify peptides by their amino acid sequence and CAS number (307297-39-8 for Epithalon/Epitalon), not by spelling alone. Supplier documentation may use either term, but the synthesis protocol and final product are identical when sourced from accredited facilities operating under cGMP (current Good Manufacturing Practice) standards.

Epithalon vs Epitalon: Full Comparison

Here's the structural, functional, and regulatory comparison that clarifies why both names persist and what matters for research applications.

Key Takeaways

• Epithalon and Epitalon are the same tetrapeptide (Ala-Glu-Asp-Gly). The spelling difference is purely a transliteration artefact from Russian Cyrillic into English.
• The peptide was synthesised in the 1980s by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology as a stable synthetic version of naturally occurring epithalamine.
• Epithalon functions as a telomerase activator by upregulating the hTERT gene, which extends telomere length and delays cellular senescence in experimental models.
• Both names appear in peer-reviewed research. PubMed returns published studies using either spelling interchangeably across decades.
• When sourcing peptides, verify by CAS number (307297-39-8) and amino acid sequence confirmation. Not by which spelling the supplier uses on the label.
• Research in animal models demonstrated a 25% extension of mean lifespan and delayed age-related pathology, including tumour development and immune decline.

What If: Epithalon and Epitalon Scenarios

What If a Supplier Lists Both Epithalon and Epitalon as Separate Products?

Request the certificate of analysis (CoA) for both listings. If the amino acid sequence, molecular weight, and purity percentage are identical, they're the same peptide listed twice under different transliterations. Reputable suppliers will confirm this when asked directly. If they cannot, that's a signal to source elsewhere. The peptide's structure should be verified by HPLC and mass spectrometry regardless of the label name.

What If Research Papers Use Different Names in the Same Study?

This occurs when a study cites earlier Russian research (which used Epithalon) alongside Western synthesis protocols (which often used Epitalon). The authors are referencing the same compound. Context clues include identical molecular weights, CAS numbers, or descriptions of the peptide as 'a synthetic analogue of epithalamine.' If the study provides structural data, compare the amino acid sequences directly.

What If I Need to Reference This Peptide in a Research Protocol?

Use the IUPAC systematic name (H-Ala-Glu-Asp-Gly-OH) or the full amino acid sequence in parentheses after the common name. Example: 'Epithalon (Ala-Glu-Asp-Gly)' or 'Epitalon (CAS 307297-39-8).' This eliminates ambiguity and ensures that anyone replicating your protocol knows exactly which peptide you used, regardless of regional naming conventions.

The Straightforward Truth About Epithalon vs Epitalon

Here's the honest answer: the 'difference' is a myth perpetuated by inconsistent transliteration and decades of unsynchronised documentation. Epithalon and Epitalon are the same molecule. Ala-Glu-Asp-Gly. Synthesised identically in labs worldwide. The confusion benefits no one except suppliers who list the peptide twice under different names to capture search traffic from researchers unsure which term is 'correct.'

The peptide's biological activity. Telomerase activation, melatonin regulation, and lifespan extension in animal models. Is replicated across studies using both names. What matters is the molecular structure confirmed by third-party testing, not the label. Researchers wasting time cross-referencing both terms in literature searches or questioning whether they need to source 'both versions' are solving a problem that doesn't exist chemically.

If you're designing a protocol or sourcing peptides, reference the CAS number (307297-39-8), verify the amino acid sequence by CoA, and move forward. The spelling debate is a distraction from the actual research question: does this peptide do what the preliminary data suggests it does? That's the inquiry worth pursuing.

How Synthesis Standards Resolve the Naming Issue

Peptide synthesis facilities operating under ISO 9001 and cGMP standards don't distinguish between Epithalon and Epitalon at the production level. The synthesis order specifies the amino acid sequence (Ala-Glu-Asp-Gly), and the final product is verified by liquid chromatography-mass spectrometry (LC-MS) to confirm molecular weight and purity. The label applied to the vial is a data field. Not a chemical specification.

Facilities supplying research institutions typically standardise their internal catalogues to one spelling for inventory management, but the synthesis protocol doesn't change when fulfilling orders listed under either name. The peptide is assembled on a solid-phase peptide synthesiser using the same reagents, protecting groups, and cleavage steps regardless of what the customer calls it. Post-synthesis purification by preparative HPLC removes truncated sequences and side products, leaving a >98% pure tetrapeptide that matches the intended structure.

For researchers comparing batches from different suppliers, the CoA is the source of truth. If two vials. One labelled Epithalon, one labelled Epitalon. Both show Ala-Glu-Asp-Gly at 390.35 g/mol with >98% purity and matching retention times on HPLC, they're functionally interchangeable in experimental protocols.

The real risk isn't the name. It's sourcing from suppliers who don't provide third-party verification. A peptide labelled 'Epithalon' without a CoA is less reliable than a peptide labelled 'Epitalon' with full LC-MS and HPLC documentation. The documentation proves the synthesis succeeded; the label is just metadata.

Understanding peptide synthesis standards matters more than memorising transliteration history. Whether you're exploring cognitive function protocols or designing longevity research, peptide integrity starts with supplier verification. Not with debating which spelling appeared first in a 1980s Russian journal.